NIH: Alzheimer’s Drug-Development Program (U01)

Name:	NIH: Alzheimer’s Drug-Development Program (U01) Application deadline: 05/06/15
General description:	Funds support for the pre-clinical and early stage clinical (Phase I) development of small-molecule and biologic therapeutic agents that prevent Alzheimer's disease (AD), slow its progression or treat its cognitive and behavioral symptoms. $1,000,000 per yr; early stage 5 yrs, late stage 3 yrs. PAR-15-174 http://grants.nih.gov/grants/guide/pa-files/PAR-15-174.html
Source:	Foreign
Budget:	$1,000,000
Number of research years:	early stage 5; late stage 3
Contact person:	Robi – 2152, robertg@technion.ac.il, Michael - 1769, MichaelKM@trdf.technion.ac.il
Fields:	Life Sciences and medicine
Type of fund:	The fund is a competitive fund
Related fund and profiles:	National Institute of Health - NIH ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner)